Answer in brief
CVE-2026-20297 records a High severity (CVSS 7.2) path traversal vulnerability in CVE-2026-20297. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
Answer in brief
CVE-2026-20297 records a High severity (CVSS 7.2) path traversal vulnerability in CVE-2026-20297. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
Review the upstream advisory, identify the affected product in your inventory, and apply the vendor update when one is available.
Path Traversal describes the vulnerability class recorded for this advisory. The current record does not mark CVE-2026-20297 as known exploited; continue to monitor the source for status changes. This is a product-level record in the current feed, not a package-level dependency mapping.
Affected software not mapped. Review the upstream record for vendor-specific product and version guidance.
In Splunk Enterprise versions below 10.4.1, 10.2.5, 10.0.8, 9.4.13, and 9.3.14, and Splunk Cloud Platform versions below 10.5.2605.0, 10.4.2604.6, 10.2.2510.18, and 10.1.2507.24, a user who holds a role that contains the `edit_local_apps` and `install_apps` capabilities could cause a legitimate app installation to write files outside the intended app directory, into `$SPLUNK_HOME/etc/` and its subdirectories.<br><br>The vulnerability is caused by a path traversal in the app installation workflow, which does not restrict the installation path to the intended app directory.
Reported by NVD (nvd).
CVE-2026-20297 records a High severity (CVSS 7.2) path traversal vulnerability in CVE-2026-20297. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
The source record does not mark it as known exploited.
Confirm whether the product or interface named by this advisory exists in your inventory.
HOL Guard can help your team monitor supply-chain activity while the upstream record is clarified.
Explore HOL GuardReview the upstream advisory, identify the affected product in your inventory, and apply the vendor update when one is available.
Path Traversal describes the vulnerability class recorded for this advisory. The current record does not mark CVE-2026-20297 as known exploited; continue to monitor the source for status changes. This is a product-level record in the current feed, not a package-level dependency mapping.
Affected software not mapped. Review the upstream record for vendor-specific product and version guidance.
In Splunk Enterprise versions below 10.4.1, 10.2.5, 10.0.8, 9.4.13, and 9.3.14, and Splunk Cloud Platform versions below 10.5.2605.0, 10.4.2604.6, 10.2.2510.18, and 10.1.2507.24, a user who holds a role that contains the `edit_local_apps` and `install_apps` capabilities could cause a legitimate app installation to write files outside the intended app directory, into `$SPLUNK_HOME/etc/` and its subdirectories.<br><br>The vulnerability is caused by a path traversal in the app installation workflow, which does not restrict the installation path to the intended app directory.
Reported by NVD (nvd).
CVE-2026-20297 records a High severity (CVSS 7.2) path traversal vulnerability in CVE-2026-20297. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
The source record does not mark it as known exploited.
Confirm whether the product or interface named by this advisory exists in your inventory.
HOL Guard can help your team monitor supply-chain activity while the upstream record is clarified.
Explore HOL Guard